These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2859740)

  • 1. The first dose hemodynamic responses to Visacor (ICI 141-292) in essential hypertension.
    Lund-Johansen P; Omvik P; Haugland H
    Acta Med Scand Suppl; 1985; 693():121-5. PubMed ID: 2859740
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate haemodynamic effects of a novel partial agonist, beta 1-adrenoceptor blocking drug ICI 141,292 after intravenous administration to healthy young volunteers and patients with ischaemic heart disease.
    Bonde J; Svendsen TL; Lyngborg K; Mehlsen J; Trap-Jensen J
    Br J Clin Pharmacol; 1987 Jan; 23(1):35-40. PubMed ID: 2880603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic studies in man with an antianginal agent 'Visacor'.
    Cockshott ID; McAinsh J; Norris S
    Biopharm Drug Dispos; 1990 Apr; 11(3):253-63. PubMed ID: 1970266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does beta 1-selective agonistic activity interfere with the antihypertensive efficacy of beta 1-selective blocking agents?
    Leonetti G; Sampieri L; Cuspidi C; Terzoli L; Rupoli L; Fruscio M; Gradnik R; Zanchetti A
    J Hypertens Suppl; 1985 Dec; 3(3):S243-5. PubMed ID: 2908819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients.
    Dahlöf B; Danielson M; Andersson O; Thulin T; Ohman P; Mörlin C; Boberg J; Karlberg BE; Jern S; Hansson L
    Br J Clin Pharmacol; 1984 Dec; 18(6):831-6. PubMed ID: 6152175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of arotinolol hydrochloride on hemodynamics, catecholamine levels and metabolism in patients with essential hypertension].
    Morimoto Y; Kasai A; Nagano K; Umino M; Kakuta Y; Iwata J; Konishi T; Hamada M; Nakano T
    Kokyu To Junkan; 1988 Mar; 36(3):311-5. PubMed ID: 2453908
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of alpha and beta blockers on hemodynamics of SHR.
    Numao Y; Iriuchijima J
    Jpn Heart J; 1974 Mar; 15(2):166-72. PubMed ID: 4152042
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
    Smith HJ; Halliday SE; Earl DC; Stribling D
    J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemodynamic correlates of selective beta 1 adrenergic receptor blockade by cordanum during hemiton monotherapy in children with primary arterial hypertension].
    Kapliev VA
    Pediatriia; 1988; (9):112. PubMed ID: 2904673
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of epanolol on intra-arterial ambulatory blood pressure and baroreceptor heart rate reflex in essential hypertension.
    Smith SA; Littler WA
    Clin Exp Pharmacol Physiol; 1988 Apr; 15(4):327-31. PubMed ID: 2908433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of a new beta-sympatholytic agent for ICI 66 082 on hemodynamics and cardiac contraction without and with experimental coronary occlusion].
    Stephan K; Bischoff KO; Geigenmüller L; Diesch J; Meesmann W
    Verh Dtsch Ges Inn Med; 1975; 81():1637-41. PubMed ID: 5832
    [No Abstract]   [Full Text] [Related]  

  • 13. Alterations in left ventricular filling with beta-adrenergic blockade.
    Fouad FM; Slominski MJ; Tarazi RC; Gallagher JH
    Am J Cardiol; 1983 Jan; 51(1):161-4. PubMed ID: 6129795
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].
    Wolf P; Feller K; Femmer K
    Pharmazie; 1975 Oct; 30(10):678-81. PubMed ID: 696
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacology of epanolol. Pharmacodynamic aspects.
    Harry JD
    Drugs; 1989; 38 Suppl 2():18-27. PubMed ID: 2575976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacoclinical study of oral butofilolol in arterial hypertension. Effects on heart rate, blood pressure and the renin-angiotensin system].
    Martinand A; Corvol P; Milliez P
    Therapie; 1983; 38(3):265-9. PubMed ID: 6137087
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic profile of carvedilol.
    Hombach V; Kochs M; Höher M; Eggeling T; Haerer W; Wieshammer S; Schmidt A
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S101-3. PubMed ID: 1974496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a new beta-adrenergic blocking agent, ICI 66o82, on exercise haemodynamics and airway resistance in angina pectoris.
    Aström H; Vallin H
    Br Heart J; 1974 Dec; 36(12):1194-1200. PubMed ID: 4155316
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects.
    Cournot A; Lim C; Duchier J; Safar M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S35-9. PubMed ID: 1378147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.